The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer

Gynecologic Oncology

Volumn 122, Issue 2, 2011, Pages 238-241

  Lee, Maria ^a   Kim, Sang Wun ^a   Nam, Eun Ji ^a   Yim, Ga Won ^a   Kim, Sunghoon ^a   Kim, Young Tae ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Epithelial ovarian cancer; Platelet count; Thrombocytosis

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; ASCITES; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE SEVERITY; EPITHELIAL OVARIAN CANCER; EPITHELIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVARY CANCER; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOSIS;

ADULT; AGED; CA-125 ANTIGEN; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBOCYTOSIS;

EID: 79960447432     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.04.012     Document Type: Article

References (23)

1. L.M. Pedersen, and N. Milman Diagnostic significance of platelet count and other blood analyses in patients with lung cancer Oncol Rep 10 1 2003 213 216
2. M. Ikeda, H. Furukawa, H. Imamura, J. Shimizu, H. Ishida, and S. Masutani Poor prognosis associated with thrombocytosis in patients with gastric cancer Ann Surg Oncol 9 3 2002 287 291 (Pubitemid 34298634)
3. I. Benoy, R. Salgado, C. Colpaert, R. Weytjens, P.B. Vermeulen, and L.Y. Dirix Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients Clin Breast Cancer 2 4 2002 311 315 (Pubitemid 34196274)
4. R.E. Schwarz, and H. Keny Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma Hepatogastroenterology 48 41 2001 1493 1498 (Pubitemid 33010454)
5. F. Gucer, K. Tamussino, F. Keil, P. Balkanli-Kaplan, and M.A. Yuce Thrombocytosis in gynecologic malignancies Anticancer Res 24 3b 2004 2053 2059 (Pubitemid 38954633)
6. G. Gastl, M. Plante, C.L. Finstad, G.Y. Wong, M.G. Federici, and N.H. Bander High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer Br J Haematol 83 3 1993 433 441 (Pubitemid 23080014)
7. T. Imai, K. Koike, T. Kubo, T. Kikuchi, Y. Amano, and M. Takagi Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro Blood 78 8 1991 1969 1974
8. A.G. van der Zee, E.M. de Cuyper, P.C. Limburg, H.W. de Bruijn, H. Hollema, and J. Bijzet Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts Cancer 75 4 1995 1004 1009
9. E. Hernandez, K.A. Donohue, L.L. Anderson, P.B. Heller, and F.B. Stehman The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study Gynecol Oncol 78 2 2000 137 142 (Pubitemid 30650343)
10. J. Menczer, E. Schejter, D. Geva, S. Ginath, and H. Zakut Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival. Eur J Gynaecol Oncol 19 1 1998 82 84 (Pubitemid 28040703)
11. A.J. Li, A.C. Madden, I. Cass, R.S. Leuchter, L.D. Lagasse, and B.Y. Karlan The prognostic significance of thrombocytosis in epithelial ovarian carcinoma Gynecol Oncol 92 1 2004 211 214 (Pubitemid 38147393)
12. A.G. Zeimet, C. Marth, E. Muller-Holzner, G. Daxenbichler, and O. Dapunt Significance of thrombocytosis in patients with epithelial ovarian cancer Am J Obstet Gynecol 170 2 1994 549 554 (Pubitemid 24089013)
13. M. den Ouden, J.M. Ubachs, J.E. Stoot, and J.W. van Wersch Whole blood cell counts and leucocyte differentials in patients with benign or malignant ovarian tumours Eur J Obstet Gynecol Reprod Biol 72 1 1997 73 77 (Pubitemid 27091287)
14. K.V. Honn, D.G. Tang, and J.D. Crissman Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev 11 3-4 1992 325 351
15. X. Qian, and G.P. Tuszynski Expression of thrombospondin-1 in cancer: a role in tumor progression Proc Soc Exp Biol Med 212 3 1996 199 207
16. G.P. Tuszynski, T.B. Gasic, V.L. Rothman, K.A. Knudsen, and G.J. Gasic Thrombospondin, a potentiator of tumor cell metastasis Cancer Res 47 15 1987 4130 4133 (Pubitemid 17108482)
17. S. Karpatkin, and E. Pearlstein Role of platelets in tumor cell metastases Ann Intern Med 95 5 1981 636 641 (Pubitemid 12231807)
18. E. Pearlstein, C. Ambrogio, and S. Karpatkin Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice Cancer Res 44 9 1984 3884 3887 (Pubitemid 14041609)
19. M. Hejna, M. Raderer, and C.C. Zielinski Inhibition of metastases by anticoagulants J Natl Cancer Inst 91 1 1999 22 36 (Pubitemid 29042440)
20. T.M. Niers, C.P. Klerk, M. DiNisio, C.J. Van Noorden, H.R. Buller, and P.H. Reitsma Mechanisms of heparin induced anti-cancer activity in experimental cancer models Crit Rev Oncol Hematol 61 3 2007 195 207 (Pubitemid 46329424)
21. S.M. Smorenburg, and C.J. Van Noorden The complex effects of heparins on cancer progression and metastasis in experimental studies Pharmacol Rev 53 1 2001 93 105 (Pubitemid 32173109)
22. L. Borsig Antimetastatic activities of heparins and modified heparins. Experimental evidence Thromb Res 125 Suppl. 2 2010 S66 S71
23. M. Demers, B. Ho-Tin-Noe, D. Schatzberg, J.J. Yang, and D.D. Wagner Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice Cancer Res 71 5 2011 1540 1549